nialamide has been researched along with trifluoperazine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jackson, DM; Jenkins, OF | 1 |
Bava, GL; Ciocatto, E; Fagiano, G | 1 |
Cramer, H; Kuhlo, W | 1 |
Pappas, BA; Vanderwolf, CH | 1 |
PARE, CM; REES, L; SAINSBURY, MJ | 1 |
SHAPIRO, AK | 1 |
2 review(s) available for nialamide and trifluoperazine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
RATIONAL USE OF PSYCHOPHARMACEUTIC AGENTS.
Topics: Antidepressive Agents; Barbiturates; Chlorpromazine; Imipramine; Isocarboxazid; Meprobamate; Nialamide; Perphenazine; Psychopharmacology; Thioridazine; Toxicology; Tranquilizing Agents; Trifluoperazine; Triflupromazine | 1964 |
6 other study(ies) available for nialamide and trifluoperazine
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Dopamine; Drug Interactions; Male; Nialamide; Nucleus Accumbens; Rats; Rats, Inbred Strains; Stereotyped Behavior; Trifluoperazine | 1986 |
Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs.
Topics: Adult; Amitriptyline; Drug Antagonism; Drug Interactions; Drug Synergism; Female; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nialamide; Poisoning; Tranylcypromine; Trifluoperazine | 1972 |
[Effects of inhibitors of monoamine oxidase on sleep and the electroencephalogram in man].
Topics: Adult; Brain; Depression; Electroencephalography; Eye Movements; Female; Humans; Male; Middle Aged; Nialamide; Sleep; Tranylcypromine; Trifluoperazine | 1967 |
Reserpine abolishes movement-correlated atropine-resistant neocortical low voltage fast activity.
Topics: Animals; Atropine; Cerebral Cortex; Chlorpromazine; Evoked Potentials; Male; Motor Activity; Nialamide; Pimozide; Rats; Reserpine; Trifluoperazine | 1980 |
Differentiation of two genetically specific types of depression by the response to anti-depressants.
Topics: Antidepressive Agents; Depression; Depressive Disorder; Imipramine; Iproniazid; Isocarboxazid; Monoamine Oxidase Inhibitors; Nialamide; Trifluoperazine | 1962 |